NICE recommends disease-modifying antirheumatic drugs (DMARDs) such as methotrexate as first-line treatment, with biologic therapies (TNF inhibitors, IL-6 inhibitors) or JAK inhibitors for patients with inadequate response
Abbreviations BMI, Body mass index
GLP-1 Drugs for Parkinsons Disease Its important to first point out that there are no disease-modifying interventions for Parkinsons disease
Look for these signs: Covering ears or eyes frequently Escaping or withdrawing from busy environments Irritability, crying, or emotional outbursts Clumsiness or uncoordinated movement Repetitive behaviors like rocking, pacing, or hand-flapping Trouble focusing or shutting down in stimulating settings If these behaviors appear frequently, it may be helpful to introduce sensory breaks during high-demand parts of the day, like transitions or after school
Delta Sleep-Inducing Peptide (DSIP): A Tool for Investigating the Sleep Onset Mechanism